By Michael Erman Oct 13 (Reuters) – Johnson & Johnson reported a slightly higher-than-expected profit on Tuesday, driven by strong sales of immune disease treatment Tremfya, but geopolitical issues
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By David Latona Oct 13 (Reuters) - Netflix said on Tuesday it had secured the…
(adds details, background) By David Latona Oct 13 (Reuters) - Netflix said on Tuesday it…
VIDEO SHOWS: HIGHLIGHTS OF AFC CHAMPIONS LEAGUE ELITE EAST REGION GAME - NEWCASTLE JETS HOST…
By Tatiana Bautzer and Prakhar Srivastava Oct 13 (Reuters) - Citigroup beat Wall Street estimates…
Oct 12 (Reuters) - Chatbot platform Character.AI said on Monday it has filed for bankruptcy…
Oct 13 (Reuters) - Netflix said on Tuesday it had secured the rights to broadcast…